Info: 120 Veg. Capsules (500 mg)
When used as a part of a healthy post-exercise regime L-Carnitine may reduce recovery time and ensure that a trip to the gym doesn't result in having to spend a day in bed to let your body rejuvenate itself. It also helps support fat metabolism.
Info: 120 Veg. Capsules (500 mg)
When used as a part of a healthy post-exercise regime L-Carnitine may reduce recovery time and ensure that a trip to the gym doesn't result in having to spend a day in bed to let your body rejuvenate itself. It also helps support fat metabolism.
Product Notes:
L-Carnitine is found in the amino acid lysine. It helps delay fatigue during physical activity and aids the body's recovery from muscle tissue damage, and so may be particularly useful to take as an adjunct to exercising, to help rejuvenate muscles as well as reduce the effects of oxidative stress caused by exercise.
Related Product: See AOR ALCAR Acetyl L-Carnitine
Ingredients:
Each capsule contains:
500 mg L-Carnitine (Tartrate)
Non-medicinal ingredients: sodium stearyl fumarate. Capsule: hypromellose.
AOR guarantees that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, dairy, soy, eggs, fish, shellfish, or any animal byproduct.
Vegan. Non-GMO. Gluten-free.
Health Canada Natural Product Number: 80039406.
Suggested Usage:
Adult Dosage: Take two (2) capsules twice daily, with food, or as directed by a qualified health care practitioner.
Warnings:
Consult a health care practitioner prior to using AOR L-Carnitine if you are pregnant or breastfeeding, or if you have a liver or kidney disease or seizure disorder.
Supporting Science:
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. Journal of Clinical Endocrinology and Metabolism. 2001 Aug.
National Kidney Foundation Carnitine Consensus Conference. Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference. American Journal of Kidney Diseases. 2003 Apr.